Human Emmprin CD147 ELISA kit
- Known as:
- Human Emmprin CD147 Enzyme-linked immunosorbent assay test reagent
- Catalog number:
- LF-EK50719
- Product Quantity:
- 1
- Category:
- Elisa Kits
- Supplier:
- Abfron
- Gene target:
- Human Emmprin CD147 ELISA kit
Related genes to: Human Emmprin CD147 ELISA kit
- Gene:
- BSG NIH gene
- Name:
- basigin (Ok blood group)
- Previous symbol:
- OK
- Synonyms:
- EMMPRIN, CD147, EMPRIN
- Chromosome:
- 19p13.3
- Locus Type:
- gene with protein product
- Date approved:
- 1993-10-25
- Date modifiied:
- 2019-04-23
Related products to: Human Emmprin CD147 ELISA kit
Related articles to: Human Emmprin CD147 ELISA kit
- Medulloblastoma (MB) in children is highly heterogeneous, leading to its classification into molecular subgroups and resulting in significant differences in clinical outcomes even within the same risk group. This heterogeneity severely hampers the clinical management of MB. Therefore, it is essential to characterize MB heterogeneity within its tumor microenvironment. - Source: PubMed
Publication date: 2026/09/15
Chen MingzeDuan BailinZhang JiaoDaniels CraigHu CuilingYuan JingzheGuo JirongTaylor Michael DShi XiangjunZhang LiweiLi DelingSun Tao - Fenestrated and branched endovascular repair (F/B-EVAR) for thoracoabdominal (TAAA) and juxta/pararenal (J/P-AAA) aortic aneurysms has shown good mid- and long-term outcomes; however, the bridging stent graft (BSG) choice remains debated. A new low-profile BSG, The GORE VIABAHN VBX Balloon Expandable (BX) was introduced in December 2024. The aim was to report the BX preliminary outcomes in F/B-EVAR. - Source: PubMed
Caputo StefaniaGallitto EnricoCappiello AntonioMorreale SilviaVacirca AndreaSpath PaoloPini RodolfoFaggioli GianlucaMascoli ChiaraGargiulo Mauro - Orofacial granulomatosis (OFG) is strongly associated with Crohn's disease (CD). The CD phenotype associated with OFG is poorly defined, and there is little evidence regarding treatment. We aimed to characterize OFG-associated CD phenotypes and evaluate the response of OFG to advanced therapies in the largest cohort described to date. - Source: PubMed
Lees Robert DPatel PriyankaYoung GregoryBeck LaurenMarin Angelica MolinilloParkinson DanielPele LaetitiaParkes MilesSanderson JeremyHerbert CameronHullah EstherLamb Christopher AMawdsley JoelSpeight Richard Ally - : Congenital pulmonary airway malformation (CPAM) is a rare developmental disorder characterized by cystic lung lesions, yet its extracellular matrix (ECM) composition remains poorly understood. This study employed decellularization and data-independent acquisition (DIA) proteomics to compare ECM profiles between cystic (CPAM) and histologically normal non-diseased (ND) regions from the lungs of four patients. : The decellularized scaffolds retained their native architecture with minimal residual DNA (<50 ng/mg). Proteomic analysis revealed 431 differentially expressed proteins (DEPs), with 171 upregulated and 260 downregulated in CPAM. Key findings revealed CPAM-specific enrichment of collagens (COL4A6, COL4A2, COL10A1, COL21A1 and PIIINP), glycoproteins (SPP1, FRAS1, FREM1, FREM2, LTBP1 and FBLN7), ECM regulators (TENM2, ROR2 and OMD), and ECM-affiliated proteins (ANXA7), alongside downregulation of glycoproteins (VASN and ABI3BP), proteoglycans (PODN and MXRA7), ECM regulators (SCARA5, PAPPA, SAA4, CPXM1, CTSC, THY1, SERPINA6/A1/D1, BSG, LYVE1, ITIH4 and CD44), and ECM-affiliated proteins (LGALSL). Pathway analysis highlighted the dysregulation of TGF-β, PI3K-AKT, and mTOR signaling in CPAM and aberrant ECM-cell interactions in pathogenesis. We also evaluated their functional properties and investigated the impact of ECM-based hydrogels on recellularization. : These findings provide a comprehensive proteomic atlas of CPAM ECM alterations, offering insights into disease mechanisms and potential therapeutic targets. - Source: PubMed
Publication date: 2026/08/30
Li YananYang PingYuan MiaoZhu XinglongMao ShengqiangYang YingYao MenglinChen FeiZhou YanyanBao JiXu ChangLi Yi - The recyclability of pots made entirely from brewer's grains (BSGs) and poly(butylene succinate) (PBS) at a PBS/BSG weight ratio of 70:30, hereafter referred to as MIXr, was evaluated. The resulting pots exhibited tensile strength at break comparable to that of conventional fossil-based polymeric materials. The study aimed to determine the maximum content of recycled materials that could be incorporated into virgin (PBSv) while maintaining acceptable properties, thereby extending the material's life cycle through mechanical recycling before disposal via biodegradation or composting. For comparison, blends of virgin PBS with recycled PBS (PBSv-PBSr) and recycled BSG/PBS material (PBSv-MIXr) were prepared at the same recycled-material contents. The materials were characterized in terms of processability, tensile properties, thermal stability (TGA), chemical group analysis (FTIR), and surface properties. The results showed that the presence of BSG significantly influences the recyclability of the biocomposite. While virgin PBS could incorporate up to 10 wt.% recycled PBS without a significant loss in ductility or thermal stability, PBSv-MIXr blends exhibit a ~20-30% reduction in deformability at MIXr contents ranging from 2 wt.% to 20 wt.% and a reduction in thermal stability ranging from 16-22% at levels of incorporation ranging between 10 wt.% and 40 wt.%. - Source: PubMed
Publication date: 2026/08/31
Visco AnnamariaSindona GianmarcoScolaro CristinaBrahimi Salim